Dr. Zhou Chenliang from Shanghai Zerun Selected for 2024 Shanghai “Oriental Talents Program” Youth Project
Zerun Biotech’s Bivalent HPV Vaccine Granted Marketing Authorization in Indonesia
Shanghai Zerun’s Bivalent HPV Vaccine Passed WHO Prequalification, Filling Global Supply Gap
Three Employees from Shanghai Zerun Biotech Selected for Pudong New Area’s First “Mingzhu Program” Talent Initiative
Shanghai Zerun Biotech Recognized as “Shanghai Technology Giant (Incubation)” Enterprise
Leaders from Pudong New Area Health Commission and Health Supervision Institute Conduct Official Inspection at Shanghai Zerun Biotech